Suppr超能文献

患有非毒性甲状腺肿或自身免疫性甲状腺疾病的规律月经女性中巨泌乳素血症的患病率。

Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease.

作者信息

Lewandowski Krzysztof C, Gąsior-Perczak Danuta, Kowalska Aldona, Lewiński Andrzej

机构信息

Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland.

出版信息

Thyroid Res. 2012 Dec 17;5(1):20. doi: 10.1186/1756-6614-5-20.

Abstract

BACKGROUND

The so called "big-big" prolactin (Prl), also known as macroprolactin is formed by Prl-immunoglobulin (Prl-IgG) complexes and may cause elevation of serum Prl concentrations measured by standard assays, potentially leading to unnecessary investigations and/or treatment. In our study, we have endeavoured to assess the prevalence of macroprolactinaemia in euthyroid, regularly menstruating women with thyroid disease, as well as to assess whether autoimmune thyroid disease may result in an increased prevalence of macroprolactinaemia.

MATERIAL AND METHODS

We measured serum Prl in 182 regularly menstruating women aged 32.7 ± 7.5 years (mean ± SD, range 17-46 years) who attended endocrine clinic either for investigation of non-toxic goitre (n = 86, age 33.2 ± 7.8 years) or with autoimmune thyroid disease (n = 96, age 32.3 ± 7.2 years). Autoimmune thyroid disease was defined as raised titre of at least one anti-thyroid antibody [anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-Tg) and/or anti-TSH-receptor (anti-TSH-R) antibodies]. All women were clinically and biochemically euthyroid, either without or on treatment with L-thyroxine. In those with raised Prl (i.e., above 530 mIU/l) we ruled out the presence of macroprolactinaemia by polyethylene glycol (PEG) precipitation method.

RESULTS

There was no significant age difference between women with and without autoimmune thyroid disease (p = 0.84). Raised Prl concentrations were found in 10 women with thyroid disease (5.5%), and of those a significant macroprolactinaemia (i.e., reduction of Prl concentrations of more than 60% after PEG precipitation) was found in 9 subjects (4.94%). There were no differences in the prevalence of macroprolactinaemia between women with autoimmune thyroid disease (4 out of 96), and without autoimmune thyroid disease (5 out of 86, p = 0.75).

CONCLUSIONS

Approximately one out of twenty women with regular menses is likely to have raised serum Prl that is usually caused by the presence of macroprolactinaemia. Though structure of macroprolactin involves Prl-IgG complexes, there is no evidence that autoimmune thyroid disease is associated with raised prevalence of macroprolactinaemia.

摘要

背景

所谓的“大大”催乳素(Prl),也称为巨催乳素,由Prl-免疫球蛋白(Prl-IgG)复合物形成,可能导致标准检测方法测得的血清Prl浓度升高,这可能会导致不必要的检查和/或治疗。在我们的研究中,我们试图评估甲状腺功能正常、月经规律的甲状腺疾病女性中巨催乳素血症的患病率,并评估自身免疫性甲状腺疾病是否可能导致巨催乳素血症患病率增加。

材料与方法

我们测量了182名年龄在32.7±7.5岁(平均±标准差,范围17 - 46岁)、月经规律的女性的血清Prl,这些女性因非毒性甲状腺肿(n = 86,年龄33.2±7.8岁)或自身免疫性甲状腺疾病(n = 96,年龄32.3±7.2岁)就诊于内分泌门诊。自身免疫性甲状腺疾病定义为至少一种抗甲状腺抗体[抗甲状腺过氧化物酶(抗TPO)、抗甲状腺球蛋白(抗Tg)和/或抗促甲状腺激素受体(抗TSH-R)抗体]的滴度升高。所有女性临床和生化检查均甲状腺功能正常,未接受或正在接受左甲状腺素治疗。对于Prl升高(即高于530 mIU/l)的患者,我们通过聚乙二醇(PEG)沉淀法排除巨催乳素血症的存在。

结果

患有和未患有自身免疫性甲状腺疾病的女性之间年龄无显著差异(p = 0.84)。在10名甲状腺疾病女性中发现Prl浓度升高(5.5%),其中9名受试者(4.94%)存在显著的巨催乳素血症(即PEG沉淀后Prl浓度降低超过60%)。患有自身免疫性甲状腺疾病的女性(96名中有4名)和未患有自身免疫性甲状腺疾病的女性(86名中有5名)之间巨催乳素血症的患病率无差异(p = 0.75)。

结论

大约每二十名月经规律的女性中就有一名可能血清Prl升高,这通常是由巨催乳素血症引起的。虽然巨催乳素的结构涉及Prl-IgG复合物,但没有证据表明自身免疫性甲状腺疾病与巨催乳素血症患病率升高有关。

相似文献

3
Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Clin Endocrinol (Oxf). 2009 Nov;71(5):702-8. doi: 10.1111/j.1365-2265.2009.03570.x. Epub 2009 Mar 28.
5
The natural history of macroprolactinaemia.
Eur J Endocrinol. 2012 Apr;166(4):625-9. doi: 10.1530/EJE-11-1007. Epub 2012 Jan 12.
6
Clinical and radiological features of patients with macroprolactinaemia.
Clin Endocrinol (Oxf). 2003 Sep;59(3):339-46. doi: 10.1046/j.1365-2265.2003.01852.x.
8
A possible cause of the variable detectability of macroprolactin by different immunoassay systems.
Clin Chem Lab Med. 2016 Apr;54(4):603-8. doi: 10.1515/cclm-2015-0484.
10
A practical method for the detection of macroprolactinaemia using ultrafiltration.
Clin Endocrinol (Oxf). 2003 Jun;58(6):686-90. doi: 10.1046/j.1365-2265.2003.01721.x.

本文引用的文献

1
The autoimmune bases of infertility and pregnancy loss.
J Autoimmun. 2012 May;38(2-3):J266-74. doi: 10.1016/j.jaut.2011.11.016. Epub 2012 Jan 27.
2
Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity.
J Autoimmun. 2012 May;38(2-3):J275-81. doi: 10.1016/j.jaut.2011.11.014. Epub 2012 Jan 3.
3
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88. doi: 10.1210/jc.2010-1692.
4
Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Clin Endocrinol (Oxf). 2009 Nov;71(5):702-8. doi: 10.1111/j.1365-2265.2009.03570.x. Epub 2009 Mar 28.
5
Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
Clin Endocrinol (Oxf). 2009 Apr;70(4):599-605. doi: 10.1111/j.1365-2265.2008.03402.x. Epub 2008 Sep 2.
7
Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s).
J Clin Endocrinol Metab. 2007 Jun;92(6):2038-40. doi: 10.1210/jc.2007-0808.
8
Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases.
J Clin Endocrinol Metab. 2007 Jun;92(6):2176-81. doi: 10.1210/jc.2006-2748. Epub 2007 Mar 6.
9
Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
Endocrinology. 2007 May;148(5):2465-70. doi: 10.1210/en.2006-1208. Epub 2007 Feb 15.
10
[Hyperprolactinemia: causes, diagnosis, and treatment].
Endokrynol Pol. 2006 Nov-Dec;57(6):656-62.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验